Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results , with sales up 2.3% year on year to $748.8 million. On the other hand, the company’s full-year revenue ...
For 2025, West Pharmaceutical guided for sales between $2.88 billion and $2.91 billion as well as adjusted earnings per-share in the range of $6 and $6.20. Analysts polled by FactSet expected $3.04 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback